Acute Variegate Porphyria in a Professional Bodybuilder after Starting a High-protein Diet and Treatment with Testosterone
DOI:
https://doi.org/10.2340/00015555-3769Keywords:
porphyria, variegate porphyria, diet, heme biosynthesisAbstract
Abstract is missing (Short communication)
Downloads
References
Anderson KE, Bloomer JR, Bonkovsky H, Kushner JP, Pierach CA, Pimstone NR, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142: 439-450.
DOI: https://doi.org/10.7326/0003-4819-142-6-200503150-00010
Balwani M, Desnick RJ. The porphyrias: advances in diagnosis and treatment. Blood 2012; 120: 4496-4504.
DOI: https://doi.org/10.1182/blood-2012-05-423186
Siegesmund M, van Tuyll van Serooskerken AM, Poblete-Gutiérrez P, Frank J. The acute hepatic porphyrias: current status and future challenges. Best Pract Res Clin Gastroenterol 2010; 24: 593-605.
DOI: https://doi.org/10.1016/j.bpg.2010.08.010
Stölzel U, Doss MO, Schuppan D. Clinical guide and update on porphyrias. Gastroenterology 2019; 157: 365-381.
DOI: https://doi.org/10.1053/j.gastro.2019.04.050
Bonkovsky HL, Dixon N, Rudnick S. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Mol Genet Metab 2019; 128: 213-218.
DOI: https://doi.org/10.1016/j.ymgme.2019.03.002
Stein PE, Badminton MN, Rees DC. Update review of the acute porphyrias. Br J Haematol 2017; 176: 527-538.
DOI: https://doi.org/10.1111/bjh.14459
Cuny JF. Porphyries cutanées. Ann Dermatol Venereol 2019; 146: 143-159.
DOI: https://doi.org/10.1016/j.annder.2018.12.005
Philipps JD. Heme biosynthesis and the porphyrias. Mol Genet Metab 2019; 128: 164-177.
DOI: https://doi.org/10.1016/j.ymgme.2019.04.008
Singal AK, Anderson KE. Variegate porphyria. 2013 Feb 14 [updated 2019 Dec 12]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. GeneReviews®. Seattle, WA: University of Washington, Seattle; 1993-2020.
Handschin C, Lin J, Rhee J, Peyer AK, Chin S, Wu PH, et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1a. Cell 2005; 122: 505-515.
DOI: https://doi.org/10.1016/j.cell.2005.06.040
Weinlich G, Doss MO, Sepp N, Fritsch P. Variegate porphyria with coexistent decrease in porphobilinogen deaminase activity. Acta Derm Venereol 2001; 81: 356-359.
DOI: https://doi.org/10.1080/000155501317140098
Balwani M, Sardh E, Ventura P, Peiró PA, Rees DC, Stölzel U, et al. Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria. NEJM 2020; 382: 2289-2301.
DOI: https://doi.org/10.1056/NEJMoa1913147
Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute hepatic porphyrias: review and recent progress. Hepatol Commun 2018; 3: 193-206.
DOI: https://doi.org/10.1002/hep4.1297
Di Pierro E, Granata F. Nutrients and porphyria: an intriguing crosstalk. Int J Mol Sci 2020; 21: 3462.
DOI: https://doi.org/10.3390/ijms21103462
Lane PR, Massey KL, Worobetz LJ, Jutras MN, Hull PR. Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol). J Am Acad Dermatol 1994; 30: 308-312.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Christiane S. Cussigh, Nina Trenkler, Jochen H.O. Hoffmann, Alexander H. Enk, Anke S. Lonsdorf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
